A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS

被引:25
作者
Hilleman, MR [1 ]
机构
[1] Merck Inst Therapeut Res, Merck Res Labs, W Point, PA 19486 USA
关键词
simplified vaccinology; vaccine against AIDS;
D O I
10.1016/S0264-410X(97)00272-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccinology is the science and engineering of developing vaccines to prevent infectious diseases. Guidelines come from knowledge of pathogenesis and from successful past vaccines. The vaccine enterprise relies on the evolution of appropriate science and technology. Governmental support and industrial participation are key to successful development of new vaccines. A large challenge for vaccinology is a vaccine which protects against AIDS. Though misguided in its first decade, current vaccine research is directed to use of any and all viral antigens and to elicit both cell-mediated and humoral immune responses that are resident, with memory, at the mucosal sites of viral entry. Recent seminal discoveries guiding the future include selective elicitation of both Type 1 and Type 2 immune responses, and prime-boosting using recombinant viral or DNA vectors and expressed antigens. Success in vaccinology depends on simplification of the complex and on iterative processes in a well-defined pathway. The present and future of vaccinology are discussed in depth. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:778 / 793
页数:16
相关论文
共 71 条
  • [61] Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression
    Schnorr, JJ
    Xanthakos, S
    Keikavoussi, P
    Kampgen, E
    TerMeulen, V
    SchneiderSchaulies, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 5326 - 5331
  • [62] Vaccine strategies: Selective elicitation of cellular or humoral immunity?
    Shearer, GM
    Clerici, M
    [J]. TRENDS IN BIOTECHNOLOGY, 1997, 15 (03) : 106 - 109
  • [63] Anti-HIV env immunities elicited by nucleic acid vaccines
    Shiver, JW
    Davies, ME
    Yasutomi, Y
    Perry, HC
    Freed, DC
    Letvin, NL
    Liu, MA
    [J]. VACCINE, 1997, 15 (08) : 884 - 887
  • [64] TH2 CELL CLONAL ANERGY AS A CONSEQUENCE OF PARTIAL ACTIVATION
    SLOANLANCASTER, J
    EVAVOLD, BD
    ALLEN, PM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1195 - 1205
  • [65] Regulation of apoptosis by viral gene products
    Teodoro, JG
    Branton, PE
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (03) : 1739 - 1746
  • [66] CROSS-CLADE NEUTRALIZATION OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN MONOCLONAL-ANTIBODIES AND TETRAMERIC CD4-IGG
    TRKOLA, A
    POMALES, AB
    YUAN, H
    KORBER, B
    MADDON, PJ
    ALLAWAY, GP
    KATINGER, H
    BARBAS, CF
    BURTON, DR
    HO, DD
    MOORE, JP
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 6609 - 6617
  • [67] Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    Trkola, A
    Purtscher, M
    Muster, T
    Ballaun, C
    Buchacher, A
    Sullivan, N
    Srinivasan, K
    Sodroski, J
    Moore, JP
    Katinger, H
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1100 - 1108
  • [68] Wang B, 1997, VACCINE, V15, P821
  • [69] Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype
    Weber, J
    Fenyo, EM
    Beddows, S
    Kaleebu, P
    Bjorndal, A
    Osmanov, S
    Heyward, W
    Esparza, J
    GalvaoCastro, B
    vandePerre, P
    Karita, E
    Wasi, C
    Sempala, S
    Tugume, B
    Biryahwaho, B
    RubsamenWaigmann, H
    vonBriesen, H
    Esser, R
    Grez, M
    Holmes, H
    Newberry, A
    Ranjbar, S
    Tomlinson, P
    Bradac, J
    McCutchan, F
    Louwagie, J
    Hegerich, P
    LopezGalindez, C
    Olivares, I
    Dopazo, J
    Mullins, JI
    Delwart, EL
    Bachmann, HM
    Goudsmit, J
    deWolf, F
    Hahn, BH
    Gao, F
    Yue, L
    Saragosti, S
    Schochetman, G
    Kalish, M
    Luo, CC
    George, R
    Pau, CP
    CheingsongPopov, R
    Nara, P
    Albert, J
    Myers, G
    Korber, B
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (11) : 7827 - 7832
  • [70] INDUCTION OF ANTIGEN-SPECIFIC UNRESPONSIVENESS WITH SYNTHETIC PEPTIDES - SPECIFIC IMMUNOTHERAPY FOR TREATMENT OF ALLERGIC AND AUTOIMMUNE CONDITIONS
    WRAITH, DC
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 108 (04) : 355 - 359